
### [NCIT:C8799](http://purl.obolibrary.org/obo/NCIT_C8799)
**Label:** Metastatic Epithelioid Sarcoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 53.58%
- [NCIT:C45809](http://purl.obolibrary.org/obo/NCIT_C45809) (Gain of Chromosome 11q13) 52.50%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 52.50%
- [NCIT:C36564](http://purl.obolibrary.org/obo/NCIT_C36564) (i(8)(q10)) 52.50%
- [NCIT:C36506](http://purl.obolibrary.org/obo/NCIT_C36506) (Loss of Chromosome 22q) 52.50%
- [NCIT:C36503](http://purl.obolibrary.org/obo/NCIT_C36503) (Loss of Chromosome 8p) 52.50%
- [NCIT:C36163](http://purl.obolibrary.org/obo/NCIT_C36163) (Metastatic/Recurrent Disease) 52.50%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 52.50%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 52.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) 37.86%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 37.86%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 37.86%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 37.86%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 37.86%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 37.86%


